Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Medical Engineering & Physics|February 15, 2000
A pharmacokinetic model for multiple sites discontinuous gastrointestinal absorptionY Plusquellec, C Efthymiopoulos, P Duthil, et al.Journal of Pharmacokinetics and Biopharmaceutics|April 1, 1997
Mixed effect modeling of sumatriptan pharmacokinetics during drug development. I: Interspecies allometric scalingV F Cosson, E Fuseau, C Efthymiopoulos, et al.Clinical Pharmacokinetics|August 3, 1999
Effect of renal impairment on the pharmacokinetics of intravenous zanamivirL M Cass, C Efthymiopoulos, J Marsh, et al.Clinical Pharmacokinetics|January 1, 1997
Theophylline and warfarin interaction studies with grepafloxacinC Efthymiopoulos, S L Bramer, A Maroli, et al.Antimicrobial Agents and Chemotherapy|September 1, 1992
Pharmacokinetics of [14C]FCE 22891, a penem antibiotic, following oral administration to healthy volunteersC Efthymiopoulos, M Strolin Benedetti, D Sassella, et al.Clinical Pharmacokinetics|January 1, 1997
Effect of renal impairment on the pharmacokinetics of grepafloxacinC Efthymiopoulos, S L Bramer, A Maroli, et al.Pharmaceutical Research|January 22, 2000
Forecasting the in vivo performance of four low solubility drugs from their in vitro dissolution dataE Nicolaides, E Galia, C Efthymiopoulos, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 1, 1990
Autoinduction of rifabutin metabolism in manM Strolin Benedetti, C Efthymiopoulos, D Sassella, et al.Cardiovascular Drugs and Therapy|April 1, 1990
Interaction of tertatolol with rifampicin and ranitidine pharmacokinetics and antihypertensive activityW Kirch, S Milferstädt, A Halabi, et al.European Journal of Pharmacology|October 23, 1990
In vivo interaction of cabergoline with rat brain dopamine receptors labelled with [3H]N-n-propylnorapomorphineM S Benedetti, P Dostert, D Barone, et al.Pageof 3